What is SDC?
Founded in 2005 and headquartered in Arizona, SDC operates as a specialized contract research organization (CRO) with a core focus on biostatistics, data management, and interactive response technology (IRT) services. The company serves as a vital infrastructure provider for the healthcare industry, ensuring that clinical trial data is managed with precision and regulatory compliance. By bridging the gap between raw clinical data and actionable insights, SDC enables its clients to accelerate the development of life-saving therapies and diagnostic tools. Its market position is defined by a deep technical expertise in statistical analysis, which is essential for the rigorous validation required by global health authorities.
How much funding has SDC raised?
SDC has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in SDC
PPP
Public-Private Partnership
What's next for SDC?
With the recent capital injection, SDC is well-positioned to enhance its technological infrastructure and expand its service capacity to meet the growing demand for high-fidelity clinical data management. The strategic focus will likely center on integrating advanced analytics and automation into its existing service suite, thereby increasing operational efficiency for its diverse client base. As the biopharmaceutical landscape continues to evolve toward more complex, data-intensive trial designs, SDC's ability to provide scalable, reliable, and compliant data solutions will be a key driver of its long-term growth. The firm is expected to leverage this financial backing to strengthen its competitive advantage in the CRO market, potentially exploring new therapeutic areas or expanding its footprint in the global clinical research ecosystem.
See full SDC company page
